Home / Advancing Research with Proteomics

Novel Insights from SOMAmer Proteomics

Discover how next-generation SOMAmer™ technologies are unlocking deeper biological insights and transforming proteomic research

Thursday, 8 October 2026 | University of Edinburgh, Institute for Regeneration & Repair

Join us to learn more about how SOMAmer-based proteomics can be used to evaluate the biological aging of human organs, yield insights into cell therapy efficacy, and identify potential biomarkers relevant to cancer research.

Event Details

Thursday, 8 October 2026 | 9:30 – 15:00 BST

University of Edinburgh
Institute for Regeneration & Repair, Edinburgh BioQuarter, 4-5 Little France Drive, Edinburgh. EH16 4UU
Room 1.05, IRR South

Featured Speakers

Canan Ugur-Yilmaz, PhD
Senior Field Application Scientist, Global Scientific Engagement
Illumina

Monica Reis, PhD
Group Leader, Translational in vitro Pharmacology
Resolution Therapeutics

Gavin Chapman
Clinical Research Fellow, Centre for Cardiovascular Science
University of Glasgow

Petra Hamerlik, PhD
Professor of Neuro-Oncology, Division of Cancer Sciences & Brain Tumor Charity Chair of Translational Neuro-Oncology
The University of Manchester

Sarah Harris, PhD
Senior Research Fellow, School of Philosophy, Psychology, and Language Sciences
The University of Edinburgh

Agenda

09:00-09:30 – Coffee and Arrival

09:30-10:00 – A Technology Overview of SOMAmer-Based Proteomics: SomaScan and SomaSeq
10:00-10:30 – Proteomics assessment of pharmacodynamics in cellular therapies, Monica Reis, PhD
10:30-11:00 – Coffee
11:00-11:30 – Cardiovascular risk assessment in kidney disease, Gavin Chapman
11:30-12:00 – Unlocking Brain Tumor Biomarkers with Liquid Biopsy Proteomics, Petra Hamerlik, PhD
12:00-13:00 – Lunch
13:00-13:45 – Longitudinal Studies: the Good, the Bad, and the Unclear, Sarah Harris, PhD
14:00-15:00 – Round Table Discussion

CAP:M-EMEA-02395